These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 2042708

  • 1. Inside the skin: the local immune and inflammatory milieu in leprosy.
    Scollard DM.
    Am J Trop Med Hyg; 1991 Apr; 44(4 Pt 2):17-23. PubMed ID: 2042708
    [Abstract] [Full Text] [Related]

  • 2. Immunopathology of leprosy skin lesions.
    Rea TH, Modlin RL.
    Semin Dermatol; 1991 Sep; 10(3):188-93. PubMed ID: 1931567
    [Abstract] [Full Text] [Related]

  • 3. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
    Moura DF, Teles RM, Ribeiro-Carvalho MM, Teles RB, Santos IM, Ferreira H, Fulco TO, Nery JA, Sampaio EP, Sarno EN.
    Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
    [Abstract] [Full Text] [Related]

  • 4. High expression of myeloid-related proteins 8 and 14 characterizes an inflammatorily active but ineffective response of macrophages during leprosy.
    Sunderkötter CH, Tomimori-Yamashita J, Nix V, Maeda SM, Sindrilaru A, Mariano M, Sorg C, Roth J.
    Immunology; 2004 Apr; 111(4):472-80. PubMed ID: 15056385
    [Abstract] [Full Text] [Related]

  • 5. Histopathology of the lepromatous skin biopsy.
    Massone C, Belachew WA, Schettini A.
    Clin Dermatol; 2015 Apr; 33(1):38-45. PubMed ID: 25432809
    [Abstract] [Full Text] [Related]

  • 6. Frequency and extent of thickening of the nucleated epidermis in leprosy lesions.
    Rea TH.
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):410-6. PubMed ID: 11332284
    [Abstract] [Full Text] [Related]

  • 7. Differences in predominant T cell phenotypes and distribution pattern in reactional lesions of tuberculoid and lepromatous leprosy.
    Narayanan RB, Laal S, Sharma AK, Bhutani LK, Nath I.
    Clin Exp Immunol; 1984 Mar; 55(3):623-8. PubMed ID: 6423326
    [Abstract] [Full Text] [Related]

  • 8. Reactions in borderline leprosy.
    Ramu G, Desikan KV.
    Indian J Lepr; 2002 Mar; 74(2):115-28. PubMed ID: 12708730
    [Abstract] [Full Text] [Related]

  • 9. Studies of human leprosy lesions in situ using suction-induced blisters: cell changes with IgM antibody to PGL-1 and interleukin-2 receptor in clinical subgroups of erythema nodosum leprosum.
    Bhoopat L, Scollard DM, Theetranont C, Chiewchanvit S, Nelson DL, Utaipat U.
    Asian Pac J Allergy Immunol; 1991 Dec; 9(2):107-19. PubMed ID: 1807258
    [Abstract] [Full Text] [Related]

  • 10. Differential development of CD4 and CD8 cytotoxic T cells (CTL) in PBMC across the leprosy spectrum; IL-6 with IFN-gamma or IL-2 generate CTL in multibacillary patients.
    de la Barrera S, Finiasz DM, Fink S, Valdez R, Bottasso O, Balina LM, Sasiain MC.
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):45-55. PubMed ID: 9207753
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Reversal reaction in borderline leprosy is associated with a polarized shift to type 1-like Mycobacterium leprae T cell reactivity in lesional skin: a follow-up study.
    Verhagen CE, Wierenga EA, Buffing AA, Chand MA, Faber WR, Das PK.
    J Immunol; 1997 Nov 01; 159(9):4474-83. PubMed ID: 9379047
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Detection of transforming growth factor-beta 1 in dermal lesions of different clinical forms of leprosy.
    Goulart IM, Figueiredo F, Coimbra T, Foss NT.
    Am J Pathol; 1996 Mar 01; 148(3):911-7. PubMed ID: 8774145
    [Abstract] [Full Text] [Related]

  • 16. Histopathological study of apparently normal skin of patients with leprosy.
    El-Darouti MA, Hussein S, Marzouk SA, Nabil N, Hunter NS, Mahgoub D, El-Eishi NH, Abdel-Halim MR.
    Int J Dermatol; 2006 Mar 01; 45(3):292-6. PubMed ID: 16533232
    [Abstract] [Full Text] [Related]

  • 17. Studies of human leprosy lesions in situ using suction-induced blisters. 1. Cellular components of new, uncomplicated lesions.
    Rangdaeng S, Scollard DM, Suriyanon V, Smith T, Thamprasert K, Theetranont C.
    Int J Lepr Other Mycobact Dis; 1989 Jun 01; 57(2):492-8. PubMed ID: 2526190
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. T cells bearing V beta 6 T cell receptors in the cell-mediated immune response to Mycobacterium leprae.
    Wang X, Golkar L, Uyemura K, Ohmen JD, Villahermosa LG, Fajardo TT, Cellona RV, Walsh GP, Modlin RL.
    J Immunol; 1993 Dec 15; 151(12):7105-16. PubMed ID: 8258714
    [Abstract] [Full Text] [Related]

  • 20. In situ identification of activated Ta1+ T lymphocytes in human leprosy skin lesions.
    Shen JY, Hofman FM, Gunter JR, Modlin RL, Rea TH.
    Int J Lepr Other Mycobact Dis; 1987 Sep 15; 55(3):494-8. PubMed ID: 2443587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.